Document:

CONSULTING AGREEMENT

            This CONSULTING  AGREEMENT  ("Consulting  Agreement"),  is effective
July 16, 1999 by and between Senesco  Technologies,  Inc., an Idaho  corporation
with a place of business at 34 Chambers St.,  Princeton,  NJ 08542  ("SENESCO"),
and Alan B. Bennett  Ph.D.,  whose address is Mann  Laboratories,  University of
California, Davis, CA 95616 ("Bennett"):

            WHEREAS,  SENESCO  is  engaged  in  the  business  of  research  and
development on plant genes and their cognate expressed proteins that are induced
during  or  coincident  with the onset of  senescence,  which  may  initiate  or
facilitate  senescence  of plants or plant  tissues,  together  with methods for
controlling senescence that involve altering the expression of these genes;

            WHEREAS,   Bennett  may  possess  useful   knowledge  and  technical
expertise relating to SENESCO research and product development;

            WHEREAS, SENESCO wishes to retain Bennett for professional
consulting services;

            WHEREAS,  Bennett may receive,  disclose,  learn or acquire valuable
and  proprietary   technical  and  commercial  trade  secrets  and  confidential
information of SENESCO  (collectively,  the  "Confidential  Information"),  from
SENESCO or otherwise as a result of performing  his  consulting  services  under
this Consulting Agreement;

            WHEREAS, SENESCO and Bennett wish to assure that such information be
held in secrecy and confidence by Bennett;

            NOW,  THEREFORE,  in  consideration  of the foregoing and the mutual
promises and covenants contained herein, the parties agree as follows:

I.    DEFINITIONS.

      "Technology   and  Inventions"   shall  mean  any  and  all   discoveries,
inventions,  conceived inventions and know-how,  whether or not patentable,  and
whether or not reduced to practice,  including any and all methods or processes,
test data, findings, designs, machines, devices,  apparatus,  manufactures,  and
any  improvements  and/or  any  utility  for  the  foregoing,  which  are  made,
conceived,  discovered or developed by Bennett,  whether alone or in conjunction
with  others,  which  arise  in any  way  from,  during  or as a  result  of the
performance of Bennett's  consulting  services to SENESCO under this  Consulting
Agreement  and  which  relate to the scope of this  Consulting  Agreement  under
Article II. This includes  Technology and  Inventions  arising from any research
and  development  by  Bennett  within the scope of Article II (a) as well

<PAGE>

as any technology  identified by Bennett of interest to SENESCO within the scope
of Article II (b) Such  Technology  and Inventions may or may not be protectable
in the form of a patent, a copyright or as a trade secret.

II.   SCOPE OF THE CONSULTING AND EXPERT SERVICES.

      Bennett  will  provide  consulting  and expert  services  relating to: (a)
research and  development  on plant genes and their cognate  expressed  proteins
that are induced during or coincident  with the onset of  senescence,  which may
initiate or  facilitate  senescence  of plants or plant  tissues,  together with
methods for controlling senescence that involve altering the expression of these
genes;  and  (b) the  review  of new  technologies  for  potential  acquisition,
license, investment, and related activities for SENESCO.

III.  SERVICES AND COMPENSATION.

      In consideration for a monthly payment of $5,400 (payable at the beginning
of each monthly period) and 7,500  additional  stock options (5,000 to vest upon
execution of this  agreement  and 2,500 to vest upon  completion of the services
under this  agreement),  Bennett  agrees to provide  SENESCO  with  professional
consulting  and expert  services  within the scope provided under Article II for
50%  of  his  usual  and  reasonable  monthly  time  devoted  to  his  customary
employment,  and under the terms and  conditions  specified  in this  Consulting
Agreement.

IV.   NO USE OF THIRD PARTY'S INFORMATION.

      Bennett  represents  that he can and will perform all services  under this
Consulting  Agreement  independent  of any  proprietary  information or know-how
received from or belonging to others,  including, but not limited to proprietary
information  of the  University of  California.  Bennett  represents  that he is
empowered by the  University of  California  to perform all services  under this
Consulting  Agreement  independent  of  any  obligations  to the  University  of
California  including,  but not limited to, rights of  assignment  and rights of
first  refusal  within  the  scope  of  Article  II.  Bennett  agrees  under  no
circumstances  to disclose  or use  proprietary  information  or know-how of any
third party in  performing  services for SENESCO.  Bennett will not represent as
unrestricted any processes, designs, plans, models, samples or other writings or
products that Bennett knows are either  covered by a third party's valid patent,
copyright,  or other forms of intellectual property protection,  or are under an
obligation of assignment to a third party.

      Bennett  represents  and warrants  that he is not rendering any service or
performing any research relating to the scope of this Consulting Agreement under
Article  II  hereof,  and that he

                                       2

<PAGE>

is not presently employed or engaged as a consultant to render any such services
or perform any such research other than as a consultant to SENESCO.

V.    CONFIDENTIAL INFORMATION.

      A. Confidential  Information includes all information disclosed by SENESCO
directly or indirectly to Bennett whether said disclosure is made in writing, by
submission  of samples,  orally,  or  otherwise,  including  without  limitation
information  relating  to the  matters  which are  within  the scope and are the
subject of this Agreement and all other  information  regarding  SENESCO's past,
present, or future research,  technology,  know-how,  ideas, concepts,  designs,
products,   prototypes,   processes,   machines,   business   plans,   technical
information,  drawings,  specifications  and  the  like,  and any  knowledge  or
information,  including but not limited to Technology and Inventions,  developed
by  Bennett  as a result  of work in  connection  with  this  Agreement,  except
information  which,  at the time of disclosure to Bennett or  development  under
this Agreement:

            1.    is established  by written  records to be in the public domain
                  other than as a consequence of an act of Bennett;

            2.    was in Bennett's  possession  prior to the  disclosure  and is
                  demonstrated through written records that such information was
                  in Bennett's  possession prior to disclosure from SENESCO, and
                  was not the  subject of an earlier  confidential  relationship
                  with SENESCO; or

            3.    was rightfully acquired by Bennett from a third party, who was
                  lawfully  in   possession  of  such   information   after  the
                  disclosure  and was under no obligation to SENESCO to maintain
                  its confidentiality.

      B. All  Confidential  Information  of SENESCO  disclosed to Bennett  shall
remain the sole  property  of  SENESCO.  Bennett  agrees  that the  Confidential
Information  will  be  kept  in  strict   confidence  until  such   Confidential
Information  becomes readily and  conveniently  available in the trade.  Bennett
agrees that he will not directly or indirectly disclose,  furnish,  disseminate,
make  available  or use the  Confidential  Information  except as  necessary  to
perform  the  consulting  and  expert  services  under  the  provisions  of this
Agreement.

      C.    Bennett will promptly inform SENESCO if Bennett discovers that a
third party is making or threatening to make unauthorized use of Confidential
Information.

      D. Bennett  acknowledges  that the  agreements  contained  herein are of a
special  nature and that any material  breach of this  Agreement by Bennett will
result in irreparable harm or injury to SENESCO.  Accordingly,  SENESCO shall be
entitled to seek an injunction  for specific  performance,  as well as any other
legal or equitable remedy which may be available.

                                       3

<PAGE>

VI.   DISCLOSURE OF INVENTIONS

      Bennett  shall  disclose  fully and promptly to SENESCO in writing any and
all  Technology  and  Inventions  pursuant to Articles I and II either:  made or
conceived  of as  set  forth  in  Article  II (a) or  identified  for  potential
acquisition,  license,  or  investment as set forth Article II (b), or otherwise
arising under this Consulting Agreement.

VII.  TECHNOLOGY AND INVENTIONS.

      A. Bennett hereby assigns and agrees to assign to SENESCO all right, title
and  interest  in any of the  Technology  and  Inventions  made,  conceived  of,
identified or otherwise arising under this Consulting Agreement. All information
and  know-how   relating  to  the  Technology  and  Inventions  is  also  deemed
Confidential  Information and shall be kept in confidence by Bennett pursuant to
this Agreement.

      B.  SENESCO has control of all right,  title and interest to any patent or
patent  application  drawn to the Technology and Inventions made,  conceived of,
identified  or  otherwise  arising  during the  performance  of this  Agreement.
SENESCO has the right to decide  whether or not to pursue  patent  protection on
any Technology and Inventions conceived of or made under this Agreement.

      C.  Bennett  agrees  that  SENESCO  has the right to select an attorney or
patent counsel to help secure patent protection to any Technology and Inventions
made,  conceived of,  identified,  or otherwise  arising out of this  Agreement.
Bennett  agrees that  SENESCO has the right to select an attorney  and/or  other
professionals  necessary to evaluate and/or secure any technology  identified by
Bennett arising under this Agreement.

      D. Designation of inventors in a patent  application is a matter of patent
law and shall be solely  within the  discretion of qualified  patent  counsel or
other legal representatives for SENESCO.

      E.  Bennett  shall,  at the request  and  expense of SENESCO,  at any time
during or after the  termination  of the  Agreement,  execute all  documents and
perform  all such acts as SENESCO may deem  necessary  or  advisable  to confirm
SENESCO's  sole and  exclusive  ownership  right,  title  and  interest  in such
Technology  and  Inventions  in any country.  Bennett  agrees to do all acts and
execute all  documents  at the expense and request of SENESCO  that  SENESCO may
deem necessary to enforce its rights to the Technology and Inventions, including
but  not  limited  to  assisting  in the  preparation  of  patent  applications,
assisting in  litigation,  appearing  for  depositions,  and  appearing as trial
witnesses.

                                       4

<PAGE>

      F. Nothing  contained  herein shall be considered as granting any license,
immunity or other right with respect to any  invention,  patent,  trade  secret,
know-how or  confidential  information  of SENESCO (apart from the right to make
necessary  use of the same in  rendering  Bennett's  services  hereunder)  or as
requiring either SENESCO or Bennett to enter into any subsequent agreement.

VIII. INDEPENDENT CONTRACTOR.

      Bennett's  relationship  to  SENESCO  during  the term of this  Consulting
Agreement shall be that of an independent contractor,  and not as an employee or
agent.  Bennett  may not make any  commitments,  or bind or  purport  to bind or
represent  SENESCO or any of its affiliates in any manner either as its agent or
in any other capacity.

IX.   NO CONFLICTING OBLIGATIONS.

      Bennett  represents  and warrants that he has the full power to enter into
and perform the services pursuant to this Consulting Agreement, and that Bennett
is under no  obligation  or  restriction  and will not assume any  obligation or
restriction  that would in any way  interfere  with,  be  inconsistent  with, or
present a conflict of interest  concerning his services in connection  with this
Consulting Agreement.

      In view of the highly  confidential  nature of the services to be rendered
by Bennett under this Consulting  Agreement,  Bennett hereby agrees that he will
not conduct any research,  act as a consultant,  or perform any other  services,
either directly or indirectly,  for any entity in the world which is competitive
with SENESCO relating to the subject matter provided in Article II herein during
the term of work under  this  Consulting  Agreement  and for a period of one (1)
year after the  termination  of this  Agreement  with  regard to subject  matter
within the scope of Article II(a) and for a period of six (6) months with regard
to subject  matter within the scope of Article  II(b).  The parties hereby agree
that the period of time and scope of the restrictions  specified herein are both
reasonable and justifiable to prevent harm to the legitimate  business interests
of SENESCO,  including  but not limited to preventing  transfer of  Confidential
Information  to  SENESCO's  competitors  and/or  preventing  other  unauthorized
disclosures or use of SENESCO's Technology and Inventions.

                                       5

<PAGE>

X.    RETURN OF CONFIDENTIAL INFORMATION AND TANGIBLE PROPERTY.

      The parties agree that all tangible  property  provided to or generated by
Bennett  in  connection  with  this  Consulting  Agreement,   including  without
limitation  all  samples,  Confidential  Information,  reports,  communications,
analyses, memoranda, notes, contact lists, and any other information produced in
connection  with this Consulting  Agreement  (collectively  "SENESCO  Property")
shall, upon the expiration or termination of the consulting work, be returned to
SENESCO unless otherwise directed in writing.

XI.   EFFECTIVE DATE AND LENGTH OF OBLIGATION.

      This Consulting  Agreement shall terminate one (1) year from its effective
date.  However,  if Bennett dies or becomes  incapacitated to the extent that he
cannot perform the services specified in this Consulting Agreement,  SENESCO has
the right to  terminate  this  Consulting  Agreement.  Bennett's  obligation  of
confidentiality and non-use of Confidential  Information shall continue from the
effective date, or the date that SENESCO discloses such Confidential Information
to Bennett,  and shall survive the expiration or termination of this  Consulting
Agreement until the Confidential  Information  becomes part of the public domain
through no actions of Bennett.  SENESCO's  rights under Articles V, VI, VII, and
IX shall survive termination of this Consulting Agreement.

XII.  SEVERABILITY.

      If any provision of this Consulting  Agreement should be determined by any
court of competent jurisdiction to be invalid, illegal or unenforceable in whole
or in part,  and such  determination  should  become  final,  such  provision or
portion  thereof shall be deemed to be severed or limited to the extent required
to render the remaining  provisions  and portions of this  Consulting  Agreement
enforceable,  and the Consulting  Agreement  shall be enforced to give effect to
the intention of the parties insofar as possible.

XIII. APPLICABLE LAW.

      This  Consulting  Agreement  shall be interpreted  and construed,  and the
legal  relations  created herein shall be determined in accordance with the laws
of the State of New Jersey.  Any provision or provisions of this Agreement which
in any way  contravenes the laws of any state or country in which this Agreement
is  effective  shall,  in such  state or  country as the case may be, and to the
extent of such  contravention  of local law, be deemed  separable  and shall not
affect any other provision or provisions of this Agreement.

                                       6

<PAGE>

      IN WITNESS WHEREOF,  and intending to be legally bound hereby, the parties
have executed and  delivered  this  Consulting  Agreement as of the day and year
first above written.

                                          SENESCO TECHNOLOGIES, INC.

By: /s/ Alan B. Bennett, Ph.D.            By:  /s/ Phillip Escaravage
    --------------------------                 -----------------------
    Alan B. Bennett, Ph.D.                     Phillip Escaravage
                                               Chairman

                                       7SENESCO, INC.
                               34 Chambers Street

                           Princeton, New Jersey 08542

                                                 July 12, 1999

Dr. John E. Thompson, Dean of Science
University of Waterloo
Waterloo, Ontario N2L 3G1
Canada

Dear Dr. Thompson:

     Reference  is made  to our  discussions  with  respect  to  your  rendering
consulting  services to us. In accordance with such discussions,  we propose the
following agreement between you as "CONSULTANT" and this company,  Senesco, Inc.
(hereinafter  "COMPANY").  This agreement will supersede all previous consulting
agreements entered between you and Senesco, Inc. or Senesco, LLC.

     1.  For good and valuable  consideration,  the  receipt  of which is hereby
acknowledged,  CONSULTANT agrees to render  consulting  services in the field of
controlling  senescence  in living cells,  including the research,  development,
perfection  and testing  relative  to said field of  controlling  senescence  in
living  cells,  such work being  hereinafter  referred  to as the "Field of this
Agreement."

     2.  COMPANY, through its  designated  representatives,  will request of the
CONSULTANT  exclusive  consulting services in the Field of this Agreement,  when
needed,  and  CONSULTANT  shall not  undertake any  competing  assignments,  and
CONSULTANT agrees to use his best efforts to meet such requests. Such consulting
services  will be  carried  out at the  University  of  Waterloo  facilities  at
Waterloo,  Ontario, CANADA, or elsewhere as may be agreed upon in writing by the
parties.

     3.  COMPANY will  reimburse  CONSULTANT  at a rate of $3,000 per month plus
disbursements.  Such $3,000 is payable by the COMPANY at the  beginning  of each
month (effective 5/1/99). For disbursements,  CONSULTANT shall submit an invoice
at the end of any month in which he incurs such expenses.  Invoices so submitted
shall be paid within fifteen (15 days) after receipt and approval by COMPANY.

<PAGE>

Dr. John E. Thompson
July 12, 1999
Page 2

     4.  CONSULTANT agrees to keep confidential any technical information or
data relating to the Field of this  Agreement  which is made available to him by
COMPANY or which  results from  CONSULTANT's  work for COMPANY;  and  CONSULTANT
agrees that he will not disclose  confidential  information  or data relating to
the Field of this Agreement to others without COMPANY's prior written agreement.

     5.  CONSULTANT  agrees to promptly  disclose to COMPANY any  inventions  or
improvements  made or  conceived  by him,  either  alone or jointly with others,
during  the term of this  agreement  or within  one (1) year  thereafter  in the
course of or as a result of work done  hereunder,  or as a result of information
supplied to CONSULTANT,  directly or  indirectly,  by COMPANY.  CONSULTANT  also
agrees to assign to COMPANY the CONSULTANT's entire right, title and interest in
and to any  and  all  such  inventions  and  improvements  and to  execute  such
documents  as may be  required  to file  applications  and to obtain  patents or
improvements  in the United States,  Canada or in any other country or countries
that COMPANY shall decide to file in. CONSULTANT  warrants that he does not have
any  commitments  to others under which he is obligated to assign to such others
inventions or improvements,  or right therein,  in conflict with his obligations
to COMPANY hereunder.

     6.  CONSULTANT  agrees that the  consideration  of Paragraph 1 hereunder is
full and complete  compensation for all obligations assumed by him hereunder and
for  all  inventions,   improvements  and  patent  rights  assigned  under  this
agreement.

     7.  CONSULTANT  agrees that he will not, during the term of this agreement,
perform  consulting  work for  other in the Field of this  Agreement,  or in any
related  fields that are  relevant  to the field of  controlling  senescence  in
living cells, without the prior written approval of COMPANY.

     8.  Any notices,  payments or  statements  to be made under this  agreement
shall be made to CONSULTANT at the address to which this letter is directed, and
to COMPANY  (except for  technical  reports to be made to  COMPANY's  designated
representative),  at the above identified  address,  to the attention of Phillip
Escaravage,  President, or at such other latest address designated in writing by
the parties for such purposes.

<PAGE>

Dr. John E. Thompson
July 12, 1999
Page 3

     9.  It is understood and agreed that CONSULTANT  will be serving under this
agreement as an independent contractor and that the relationship of employer and
employee shall not exist between COMPANY and CONSULTANT hereunder,  and employee
shall not exist between COMPANY and CONSULTANT  hereunder,  and CONSULTANT shall
not be  eligible  to  participate  in any  benefits  extended  by COMPANY to its
employees.

     10. The obligations set forth in Paragraphs 4 and 5 above shall survive the
termination of this agreement to the extent indicated therein.

     11. The term of this agreement shall be twenty-six  (26) months,  beginning
May 1, 1999 and ending, June 30, 2001, and shall be automatically  renewable for
two additional three-year terms, unless either of the parties notifies the other
with  written  notice (as  provided in paragraph 8) within six (6) months of the
end of the term.

     If you agree to the foregoing,  please  indicate your acceptance by signing
below and returning same to us.

                                          Very truly Yours truly,

                                          SENESCO, INC.

                                          By: /s/ Phillip Escaravage
                                             -----------------------------------
                                             Name:  Phillip Escaravage
                                             Title: President

AGREED TO AND ACCEPTED:
This 15th day of July, 1999
     ----

   /s/ John E. Thompson
-----------------------
   Dr. John E. Thompson

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00015-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00015-of-00352.parquet"}]]